Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP502394.RANz1LndUSCf9modnHuWs-B_Glfyei7nIFozcih5SsCYM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP502394.RANz1LndUSCf9modnHuWs-B_Glfyei7nIFozcih5SsCYM130_assertion type Assertion NP502394.RANz1LndUSCf9modnHuWs-B_Glfyei7nIFozcih5SsCYM130_head.
- NP502394.RANz1LndUSCf9modnHuWs-B_Glfyei7nIFozcih5SsCYM130_assertion wasGeneratedBy ECO_0000203 NP502394.RANz1LndUSCf9modnHuWs-B_Glfyei7nIFozcih5SsCYM130_provenance.
- NP502394.RANz1LndUSCf9modnHuWs-B_Glfyei7nIFozcih5SsCYM130_assertion wasDerivedFrom befree-20150227 NP502394.RANz1LndUSCf9modnHuWs-B_Glfyei7nIFozcih5SsCYM130_provenance.
- NP502394.RANz1LndUSCf9modnHuWs-B_Glfyei7nIFozcih5SsCYM130_assertion SIO_000772 16098254 NP502394.RANz1LndUSCf9modnHuWs-B_Glfyei7nIFozcih5SsCYM130_provenance.
- NP502394.RANz1LndUSCf9modnHuWs-B_Glfyei7nIFozcih5SsCYM130_assertion evidence source_evidence_literature NP502394.RANz1LndUSCf9modnHuWs-B_Glfyei7nIFozcih5SsCYM130_provenance.
- NP502394.RANz1LndUSCf9modnHuWs-B_Glfyei7nIFozcih5SsCYM130_assertion description "[Also, patients with the CXCR1 GC genotype were found to have an increased relative risk of time to tumor progression that was 1.55 (95% CI, 0.8-3.0) times that of patients with the homozygous GG genotype (P = 0.17; log-rank test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502394.RANz1LndUSCf9modnHuWs-B_Glfyei7nIFozcih5SsCYM130_provenance.